Hypera (OTCMKTS:HYPMY) Sets New 1-Year Low – Here’s What Happened

Hypera S.A. (OTCMKTS:HYPMY)’s share price reached a new 52-week low during trading on Wednesday . The stock traded as low as $2.64 and last traded at $2.70, with a volume of 10164 shares. The stock had previously closed at $2.88.

Hypera Trading Down 7.8 %

The firm’s 50-day simple moving average is $3.83 and its 200 day simple moving average is $4.73. The stock has a market cap of $1.68 billion, a P/E ratio of 5.62 and a beta of 1.02.

About Hypera

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.